Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (11-20 of 381) with videos related to

Pageof 39
Sort By:
Journal of Clinical Medicine|July 9, 2022
Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective AffinitiesAlessandro Rizzo
Thoracic Cancer|January 14, 2022
Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first-line treatment for advanced non-small cell lung cancerAlessandro Rizzo
Cancer Treatment Reviews|October 16, 2022
Considerations regarding a network meta-analysis of targeted therapies for BRAF-mutant unresectable or metastatic melanomaAlessandro Rizzo
Translational Oncology|October 17, 2021
Optimizing outcomes in HCC: Comment on "optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis" by Jiang et alAlessandro Rizzo
The Lancet. Oncology|February 3, 2022
Nivolumab plus ipilimumab in melanoma brain metastasesAlessandro Rizzo
European Journal of Cancer (Oxford, England : 1990)|July 25, 2022
Letter re: "Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis"Alessandro Rizzo, Giovanni Brandi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
The Last Dance for Chemotherapy Intensification in Non-Asian Advanced Biliary Tract Cancers?Massimiliano Salati, Alessandro Rizzo
Future Oncology (London, England)|February 3, 2022
SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debateAlessandro Rizzo, Gennaro Palmiotti
Immunotherapy|June 1, 2022
Neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: a new kid on the block?Alessandro Rizzo, Gennaro Palmiotti
Cancer Treatment and Research Communications|February 16, 2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directionsAlessandro Rizzo, Giovanni Brandi
Pageof 39

Showing results (11-20 of 381) with videos related to

Sort By:
Pageof 39
Journal of Clinical Medicine|July 9, 2022
Immune Checkpoint Inhibitors and Mismatch Repair Status in Advanced Endometrial Cancer: Elective AffinitiesAlessandro Rizzo
Thoracic Cancer|January 14, 2022
Chemoimmunotherapy versus immune checkpoint inhibitors monotherapy as first-line treatment for advanced non-small cell lung cancerAlessandro Rizzo
Cancer Treatment Reviews|October 16, 2022
Considerations regarding a network meta-analysis of targeted therapies for BRAF-mutant unresectable or metastatic melanomaAlessandro Rizzo
Translational Oncology|October 17, 2021
Optimizing outcomes in HCC: Comment on "optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis" by Jiang et alAlessandro Rizzo
The Lancet. Oncology|February 3, 2022
Nivolumab plus ipilimumab in melanoma brain metastasesAlessandro Rizzo
European Journal of Cancer (Oxford, England : 1990)|July 25, 2022
Letter re: "Long-term effectiveness of empiric cardio-protection in patients receiving cardiotoxic chemotherapies: A systematic review and Bayesian network meta-analysis"Alessandro Rizzo, Giovanni Brandi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2022
The Last Dance for Chemotherapy Intensification in Non-Asian Advanced Biliary Tract Cancers?Massimiliano Salati, Alessandro Rizzo
Future Oncology (London, England)|February 3, 2022
SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debateAlessandro Rizzo, Gennaro Palmiotti
Immunotherapy|June 1, 2022
Neoadjuvant chemoimmunotherapy in early triple-negative breast cancer: a new kid on the block?Alessandro Rizzo, Gennaro Palmiotti
Cancer Treatment and Research Communications|February 16, 2021
Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directionsAlessandro Rizzo, Giovanni Brandi
Pageof 39